Cargando…

Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy

BACKGROUND: The rapid progressive cervical spondylotic myelopathy (rp-CSM) which had a course of CSM less than 1 month and suffered rapidly progressive neurological deterioration had few reports. Therefore, it is important for us to recognize the pathophysiology of CSM especially the rp-CSM. The stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Weiyang, Wang, Lin, Huang, Tianji, Luo, Xiaoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818545/
https://www.ncbi.nlm.nih.gov/pubmed/33478509
http://dx.doi.org/10.1186/s13018-021-02227-6
_version_ 1783638857884893184
author Zhong, Weiyang
Wang, Lin
Huang, Tianji
Luo, Xiaoji
author_facet Zhong, Weiyang
Wang, Lin
Huang, Tianji
Luo, Xiaoji
author_sort Zhong, Weiyang
collection PubMed
description BACKGROUND: The rapid progressive cervical spondylotic myelopathy (rp-CSM) which had a course of CSM less than 1 month and suffered rapidly progressive neurological deterioration had few reports. Therefore, it is important for us to recognize the pathophysiology of CSM especially the rp-CSM. The study aimed to investigate the risk factors for rapidly progressive (rp) neurological deterioration in patients with cervical spondylotic myelopathy (CSM). METHODS: A total of 159 patients were reviewed and divided into an rp-CSM group and a chronic-CSM (c-CSM) group. Various clinical indexes, including age, sex, Japanese Orthopaedic Association (JOA) score, intramedullary MR T2-hyperintensity, congenital/degenerative spinal stenosis, and local type of ossification of the posterior longitudinal ligament (OPLL), were analyzed, and independent risk factors were investigated. RESULTS: Thirty-four of 159 patients (21.4%) were diagnosed with rp-CSM. All patients were followed up for a mean of 68.56 ± 14.00 months in the rp-CSM group and 62.66 ± 19.95 months in the c-CSM group. No significant difference was found in sex, mean age, smoking and drinking status, diabetes mellitus (DM), hypertension, surgery time, blood loss, JOA score, degenerative spinal stenosis, or OPLL (local). Univariate analyses demonstrated that rp-CSM patients tended to have MR T2-hyperintensity, longer hospital stay, shorter waiting time for surgery, more congenital spinal stenosis, and worse neurological function and to prefer more posterior surgeries than c-CSM patients. A multiple logistic regression analysis showed that congenital spinal stenosis and MR T2-hyperintensity were independently related to the presence of rp-CSM. CONCLUSIONS: MR T2-hyperintensity and congenital spinal stenosis were risk factors for rp-CSM. Although neurological function deteriorates rapidly, early surgical decompression is recommended and can achieve good neurological recovery after surgery, indicating that rp-CSM could be a reversible condition.
format Online
Article
Text
id pubmed-7818545
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78185452021-01-22 Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy Zhong, Weiyang Wang, Lin Huang, Tianji Luo, Xiaoji J Orthop Surg Res Research Article BACKGROUND: The rapid progressive cervical spondylotic myelopathy (rp-CSM) which had a course of CSM less than 1 month and suffered rapidly progressive neurological deterioration had few reports. Therefore, it is important for us to recognize the pathophysiology of CSM especially the rp-CSM. The study aimed to investigate the risk factors for rapidly progressive (rp) neurological deterioration in patients with cervical spondylotic myelopathy (CSM). METHODS: A total of 159 patients were reviewed and divided into an rp-CSM group and a chronic-CSM (c-CSM) group. Various clinical indexes, including age, sex, Japanese Orthopaedic Association (JOA) score, intramedullary MR T2-hyperintensity, congenital/degenerative spinal stenosis, and local type of ossification of the posterior longitudinal ligament (OPLL), were analyzed, and independent risk factors were investigated. RESULTS: Thirty-four of 159 patients (21.4%) were diagnosed with rp-CSM. All patients were followed up for a mean of 68.56 ± 14.00 months in the rp-CSM group and 62.66 ± 19.95 months in the c-CSM group. No significant difference was found in sex, mean age, smoking and drinking status, diabetes mellitus (DM), hypertension, surgery time, blood loss, JOA score, degenerative spinal stenosis, or OPLL (local). Univariate analyses demonstrated that rp-CSM patients tended to have MR T2-hyperintensity, longer hospital stay, shorter waiting time for surgery, more congenital spinal stenosis, and worse neurological function and to prefer more posterior surgeries than c-CSM patients. A multiple logistic regression analysis showed that congenital spinal stenosis and MR T2-hyperintensity were independently related to the presence of rp-CSM. CONCLUSIONS: MR T2-hyperintensity and congenital spinal stenosis were risk factors for rp-CSM. Although neurological function deteriorates rapidly, early surgical decompression is recommended and can achieve good neurological recovery after surgery, indicating that rp-CSM could be a reversible condition. BioMed Central 2021-01-21 /pmc/articles/PMC7818545/ /pubmed/33478509 http://dx.doi.org/10.1186/s13018-021-02227-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhong, Weiyang
Wang, Lin
Huang, Tianji
Luo, Xiaoji
Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy
title Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy
title_full Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy
title_fullStr Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy
title_full_unstemmed Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy
title_short Risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy
title_sort risk factors for rapid progressive neurological deterioration in patients with cervical spondylotic myelopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818545/
https://www.ncbi.nlm.nih.gov/pubmed/33478509
http://dx.doi.org/10.1186/s13018-021-02227-6
work_keys_str_mv AT zhongweiyang riskfactorsforrapidprogressiveneurologicaldeteriorationinpatientswithcervicalspondyloticmyelopathy
AT wanglin riskfactorsforrapidprogressiveneurologicaldeteriorationinpatientswithcervicalspondyloticmyelopathy
AT huangtianji riskfactorsforrapidprogressiveneurologicaldeteriorationinpatientswithcervicalspondyloticmyelopathy
AT luoxiaoji riskfactorsforrapidprogressiveneurologicaldeteriorationinpatientswithcervicalspondyloticmyelopathy